Invesco ltd: Form 8.3 - Horizon Therapeutics plc
09 Diciembre 2022 - 5:43AM
Invesco ltd: Form 8.3 - Horizon Therapeutics plc
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVERRULES, 2022 BY PERSONS WITH INTERESTS IN
RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY
INFORMATION
|
(a) Full name of
discloser |
Invesco Ltd. |
|
(b) Owner or controller
of interests and short positions disclosed, if
different from 1(a) The naming of nominee or vehicle
companies is insufficient. For a trust, the trustee(s), settlor and
beneficiaries must be named. |
|
|
(c) Name of
offeror/offeree in relation to whose relevant
securities this form relates Use a separate form for each
offeror/offeree |
Horizon Therapeutics PLC |
|
(d) If an exempt fund
manager connected with an offeror/offeree, state
this and specify identity of
offeror/offeree (Note 1) |
|
|
(e) Date position
held/dealing undertaken For an opening position
disclosure, state the latest practicable date prior to the
disclosure |
08/12/2022 |
|
(f) In addition to the
company in 1(c) above, is the discloser also
making disclosures in respect of any other party
to the offer? If it is a cash offer or possible cash
offer, state “N/A” |
N/A |
2. INTERESTS
AND SHORT POSITIONS
If there are interests and short positions to
disclose in more than one class of relevant securities of the
offeror or offeree named in 1(c), copy table 2 for each additional
class of relevant security.
Interests and short positions in the
relevant securities of the offeror or offeree to which the
disclosure relates following the dealing (if any) (Note
2)
|
Class of relevant security (Note 3) |
Common Stock IE00BQPVQZ61 |
|
|
Interests |
Short positions |
|
Number |
% |
Number |
% |
|
(1) Relevant securities
owned and/or controlled |
3,512,263 |
1.549 |
|
|
|
(2) Cash-settled
derivatives |
|
|
|
|
|
(3) Stock-settled
derivatives (including options) and
agreements to purchase/ sell |
|
|
|
|
|
Total |
3,512,263 |
1.549 |
|
|
All interests and all short positions should be
disclosed.
Details of options including rights to subscribe
for new securities and any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental
Form 8.
3. DEALINGS
(IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)
Where there have been dealings in more than one
class of relevant securities of the offeror or offeree named in
1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each
additional class of relevant security dealt in.The currency of all
prices and other monetary amounts should be stated.
(a) Purchases
and sales
|
Class of relevantsecurity |
Purchase/sale |
Number ofsecurities |
Price per unit(Note 5) |
|
Common Stock |
Purchase |
63 |
96.91 USD |
|
Common Stock |
Purchase |
11 |
96.55 USD |
|
|
|
|
|
|
|
|
|
|
(b) Cash-settled
derivative transactions
|
Class
ofrelevantsecurity |
Product description e.g. CFD |
Nature of dealinge.g. opening/ closing a long/
short position, increasing/ reducing a long/ short position |
Number ofreference
securities (Note 6) |
Price per unit (Note 5) |
|
|
|
|
|
|
(c) Stock-settled
derivative transactions (including options)
(i) Writing,
selling, purchasing or
varying
|
Class of relevant
security |
Product description e.g. call
option |
Writing, purchasing,
selling, varying
etc. |
Number of
securities to which
option relates (Note
6) |
Exerciseprice per
unit |
Type e.g. American, Europeanetc. |
Expiry date |
Option
moneypaid/
received per unit |
|
|
|
|
|
|
|
|
|
(ii) Exercise
|
Class of relevant
security |
Product description e.g. call
option |
Exercising/ exercised
against |
Number of securities |
Exercise price per
unit (Note 5) |
|
|
|
|
|
|
(d) Other
dealings (including transactions in respect of new
securities) (Note 3)
|
Class of relevant
security |
Nature of dealing e.g. subscription, conversion,
exercise |
Details |
Price per unit (if applicable)
(Note 5) |
|
|
|
|
|
4. OTHER
INFORMATION
(a) Indemnity
and other dealing arrangements
|
Details of any indemnity or option arrangement, or any
agreement or understanding, formal or informal,
relating to relevant securities which may be an
inducement to deal or refrain from dealing entered
into by the person making the disclosure and any
party to the offer or any person acting in concert
with a party to the offer. Irrevocable commitments and
letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state “none” |
|
|
(b) Agreements,
arrangements or understandings relating to
options or derivatives
|
Full details of any agreement, arrangement or
understanding between the person disclosing and
any other person relating to the voting rights of
any relevant securities under any option referred
to on this form or relating to the voting rights or future
acquisition or disposal of any relevant securities to which
any derivative referred to on this form is
referenced. If none, this should be
stated. |
|
|
(c) Attachments
|
Is a Supplemental Form 8 attached? |
NO |
|
Date of disclosure |
09/12/2022 |
|
Contact name |
Philippa Holmes |
|
Telephone number |
01491 417447 |
Public disclosures under Rule 8.3 of the Rules
must be made to a Regulatory Information Service.
Invesco (LSE:0UAN)
Gráfica de Acción Histórica
De Oct 2024 a Nov 2024
Invesco (LSE:0UAN)
Gráfica de Acción Histórica
De Nov 2023 a Nov 2024
